Active transport of small peptides has long been recognized as a strategy for diverse cell types to obtain amino acids (reviewed in reference 25) . Although the fundamental importance of this process in organisms with normal amino acid transport and biosynthetic abilities has been difficult to document, the fact that it exists in mammals (25) , fungi (31), higher plants (40) , and bacteria (33) suggests that the process provides strong selective advantages to these species.
The best understanding of peptide transport comes from investigations with the gram-negative bacteria Escherichia coli and Salmonella typhimurium (reviewed in reference 33) . At a minimum, they both have three genetically separate transport systems. The Opp permease, encoded by oppAB-CDF, can transport peptides of two to five amino acids and is linked to the trp operon in both organisms (3, 4, 17, 22) . tppB of S. typhimurium, min 27, and oppE of E. coli, min 98 (3, 9, 19) , have been implicated as being involved in transport primarily of tripeptides. Mutations affecting the transport primarily of dipeptides have been isolated in both S. typhimurium and E. coli. The loci involved have been named dpp for dipeptide permease. A dpp allele, dpp-J, was mapped in E. coli near min 14; however, no subsequent analysis of the role of this locus in peptide transport has been reported (7) . A second set of dpp mutations have been selected in E. coli by their ability to confer resistance to the toxic peptide bacilysin. Fifteen percent of these mutants had reduced levels or were missing a 49-kDa periplasmic protein, called Dpp (24) . dpp mutations in S. typhimurium mapping to min 82 have been identified and shown to cause defects in the uptake of dipeptides as well as some tripeptides (13) . The ami locus from Streptococcus penumoniae has been sequenced and found to contain five genes displaying striking similarity to the opp operon of S. typhimurium (1) . Although not proven, there is evidence that the products of the ami operon are involved in the transport of oligopeptides (1) .
In gram-negative bacteria, small-molecule transport sys-E. COLI dppA AND DIPEPTIDE TRANSPORT
MATERIALS AND METHODS
Strains and media. The E. coli strains used are K-12 derivatives and, along with the phage and plasmids, are shown in Table 1 . Liquid cultures were grown in either LB, LB+ (LB plus 0.2% glucose), or M9-based medium (28) . M9 medium was supplemented with the appropriate sugar at 0.2% and with vitamin-free casamino acids (CAA; Difco, Detroit, Mich.) where noted. Amino acids were added at 50 ,ug/ml for growth of auxotrophic strains except where noted.
Concentrations of antibiotics were: streptomycin sulfate (Sm), 100 ,ug/ml; kanamycin sulfate (Kan), 50 j,g/ml; and ampicillin (Ap), 100 jig/ml. M13-derived clones were grown in YT medium as described, with JM101 as a host (27) . Media for A growth and plating were as described before (5, 10) . Phage P1 vir was grown and used as described before (28) .
E1614 (W3110 dppA20::Kan) was made by growing E1532 (see Phage constructions [below] for E1532 derivation) at 30°C in LB and plating for isolated colonies on LB plates at 40°C. Twelve colonies were purified, and eight were Kanr.
One of the Kanr colonies, E1614, was shown to be sensitive to A imm434 infection and to contain the dppA20::Kan allele by Southern hybridization of chromosomal DNA and Western immunoblots. E1847 (JM101 dppA30::Kan) was isolated in the same manner as E1614 except that the starting strain was E1843 (see Phage constructions for E1843 derivation). The donors and recipients used for P1 transductions to create E1222, E1769, E1772, and E1974 are listed in Table 1 . E1222 was selected on LB with streptomycin, E1769 and E1772 were selected on LB with tetracycline, and E1974 was selected on LB with kanamycin containing 250 ,uM proline. E232 was isolated by growing JM101 in the presence of acridine orange (125 ,ug/ml) and screening the survivors for loss of the F' by plating on M9 with and without proline and testing for sensitivity to phage M13. One of the Pro-M13r isolates was identified as E232.
Hfr mapping. Donors containing transposon TnJO were used essentially as described before (41) . Log-phase cultures of both donor and recipient were mixed at a ratio of 5 donor to 1 recipient and mated for 30 min at 37°C with gentle shaking. The mixtures were vigorously vortexed, diluted, and plated onto LB agar containing streptomycin and tetracycline. Transconjugants were purified and assayed for DppA by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
DNA techniques. Restriction digests, agarose gel electrophoresis, large-and small-scale plasmid preparations, transformations, A DNA isolation, Southern blots, and plaque and colony hybridizations were done by standard techniques (23 Fig. 3 were sequenced.
Protein techniques. SDS-PAGE for analyzing cell extracts was done as described, with DATD (N,N'-diallyltartardiamide) as the cross-linker, and stained with Coomassie brilliant blue (21, 30) . Cell fractionation was done by osmotic shock essentially as described by Nossal and Heppel (32) . Overnight cultures were grown in the indicated media and diluted to an OD550 of 1. Then, 1 ml was centrifuged, washed in 1 ml of TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0), centrifuged, suspended in 100 ,ul of room-temperature 20% sucrose-30 mM EDTA, pH 8.0, and held for 10 min. The cells were centrifuged, suspended in 100 pAl of ice-cold 0.5 mM MgCl2 held on ice for 5 min, and then centrifuged for 5 min in a microfuge. The supernatant was saved, and the pellet was suspended in 100 pI of TE. For total cellular extract preparation, overnight cultures were centrifuged, suspended in lysis buffer (21) , and boiled for 5 min before loading.
Western blots were done with nitrocellulose as described before (37) . Procedures for subsequent treatment and processing of filters were as described by the supplier of the immunologic reagents (Bio-Rad Laboratories, Richmond, Calif.). After reaction with primary antibody, filters were reacted with protein A-horse radish peroxidase (HRP) conjugate and developed according to the manufacturer's recommendations. DppA was purified from 400 ml of JM101 grown to saturation in M9-glucose-0.02% CAA. Cells were centrifuged, sonicated, and centrifuged; the supernatant was lyophilized, suspended in 0.1 M ammonium bicarbonate, pH 7.8, and centrifuged. The pellet was discarded, and the supernatant was applied to a column (1.5 by 97.5 cm) of Bio-Gel P-6 (Bio-Rad) developed in 0.1 M ammonium bicarbonate at a flow rate of 4 ml/h. The effluent fractions were monitored for the presence of proteins and peptides by UV absorbance at 230 nm. The fraction eluting at the void volume of the column was diluted fivefold with water, applied to a column (0.9 by 10 cm) of Whatman DE- centrifuged for 15 min to separate the layers. The aqueous phase was transferred to a fresh tube, and an equal volume of isopropanol was added to precipitate the RNA. After incubation at -20°C for 45 min, the samples were centrifuged for 15 min at 10,000 rpm in a Microfuge and the resulting pellet was washed twice with 0.8 ml of 75% ethanol. The pellets were briefly dried and suspended in 0.05 ml of diethyl pyrocarbonate-treated water. Then 4.5 pug of each RNA sample was suspended in loading dye (23) , heated at 90°C for 5 min, and electrophoresed through a 1.3% formaldehyde-agarose gel (23) . RNA size standards from BRL-Gibco (Gaithersburg, Md.) were treated identically. The gel was electrophoresed overnight at 20 mA and transferred to Nytran (Schleicher & Schuell) with an LKB (Bromma, Sweden) vacuum blotter, and the RNA was fixed onto the filter by UV cross-linking. A [32P]-rCTP-labeled single-stranded antisense RNA probe was synthesized by using T7 polymerase as described by the supplier (Stratagene Inc., La Jolla, Calif.). The template for this synthesis was pBSEB-2 (see below). The filter was prehybridized for 30 min and hybridized overnight in 5 x SSC-5 x Denhardt's solution-0.1% SDS-100 pug of salmon sperm DNA per ml-50% formamide at 65C (lx SSC is 0.15 M NaCl, 0.015 M sodium citrate). The filter was washed twice in 2x SSC-0.1% SDS at 65°C and once in 0.1x SSC-0.1% SDS for 15 min at the same temperature. The RNA markers and rRNA were visualized by staining the filter, after autoradiographs were exposed, with methylene blue, as described before (29) .
Isolation of 10 and X22. Chromosomal DNA was isolated from E1222 as described before (35) and partially digested with Sau3A to yield fragments of 10 to 20 kbp. The resulting fragments were ligated with BamHI-digested XEMBL4 arms (Promega, Madison, Wisc.), packaged in vitro with Packagene Lambda DNA Packaging System (Promega) and plated on JM101, and the resulting plaques were screened with nick-translated 1.5-kbp BamHI fragment from pUC3-13 containing part of dppA. Two of the hybridizing plaques were characterized further (X10 and X22) and shown by restriction enzyme mapping and Southern hybridizations to contain dppA and flanking DNA.
Plasmid constructions. pUC3-13 and pCWB-1 were constructed by ligating the 1,465-bp BamHI fragments from X9F6 and X10, respectively, into the BamHI site of pUC18. pUC3-13K and pCWBK-2 were constructed by ligating an EcoRI fragment from pUC4K (Pharmacia, Inc., Piscataway, N.J.) containing the gene for Kanr into the EcoRI site internal to dppA in pUC3-13 and pCWB-1, respectively.
pfppl-2 was constructed as follows. Plasmid pSRlac contains the pBR322 ori and bla genes and a resynthesized version of the lac promoter (used to replace the EcoRIBamHI fragment of pBR322) situated so that transcription from lacp proceeds clockwise with respect to the standard pBR322 map. The promoter is followed by restriction sites for ClaI, HindIII, KpnI, SmaI, and BamHI. Oligonucleotides containing the start of dppA (5'-CGATAATGCGTA TTTCCTTGAAAAAGTCAGGGATGCTGA and 5'-AGCT TCAGCATCCCTGAClT1TlCAAGGAAATACGCATTAT) were annealed and ligated to ClaI-HindlI-digested pSRlac to create pfls-3. A HindIII-PstI fragment from X10 (PstI site made blunt-ended with Klenow and dNTPs), containing all but the very beginning of dppA plus 1.1 kbp downstream of dppA, was ligated into HindIII-SmaI-digested pfls-3 to generate pfppl-2. pACDF was constructed by ligating a 9-kbp EcoRI fragment from X22 containing the 3' end of dppA into the EcoRI site of pACYC184.
pBSEB was constructed by ligating the EcoRI-BamHI fragment internal to dppA from X22 into EcoRI-BamHIdigested pBS.
Phage constructions. X2-2 was made by ifecting C600 with X3H5 and G501, each at a multiplicity of infection of 5, and selecting for imm434 N+ recombinants on a lawn of K124. One of the resulting recombinants, X2-2, was shown by restriction enzyme mapping and hybridization to contain the dppA region as in X3H5. X22i4 was made similarly to X2-2 except that the cross was between X22 and G501. X1532-3 was made by growing X2-2 in JM1O1(pUC3-13K) and using the resulting lysate to lysogenize W3110. Lysogens were selected on LB-kanamycin plates at 30°C. One of these lysogens, E1532, was resistant to X mm434 but not A at 30°C. Phage was isolated from the resulting lysogen by growing the cells at 40°C and plating the resulting supernatant on a lawn of W3110. The resulting plaques were hybridized to a nick-translated DNA fragment from pUC4K containimg the gene for Kanr, and one of those that hybridized, X1532-3, was shown by restriction enzyme analysis to contain the Kanr cassette in the EcoRI site of dppA. The same steps were used to make X1843-3 except that X22i4 was grown in JM101(pCWBK-2) and the resulting phage were used to lysogenize JM101. One of these lysogens was called E1843. Phage were isolated from E1843 by heat induction, and an isolate shown to contain the Kanr insertion was identified and called X1843-3.
Dipeptide utilization. Cells were grown overnight in M9-glucose containing required amino acids, pelleted, washed in lx M9 salts, pelleted, and suspended in lx M9 salts (28) . The cultures were then diluted 1:100 in M9-glucose containing the appropriate peptide at 50 ,uM unless otherwise noted. The cultures were shaken overnight at 37°C, and the density was read at 550 nm. Peptides were purchased from Bachem Bioscience Inc., Philadelphia, Pa.
Nucleotide sequence accession number. The sequence shown in Fig. 3 has GenBank accession number M35045.
RESULTS
Characterization of DppA levels and cellular location. In efforts to expand the repertoire of elements (genetic and physiological regulatory elements, signal sequences, etc.) that would be useful in expressing heterologous genes in E. coli, we investigated the following observation. When the E. coli strain JM101 was grown in minimal medium, a 50-kDa protein accumulated in the periplasm to extremely high levels (about 10% of total cell protein and 90% of periplasmic protein, as determined from Coomassie-stained gels). If this high expression was due to a single copy of a gene, then the elements controlling its expression and secretion would be of interest. For this reason, we wished to characterize and ultimately identify the gene encoding this protein, understand the basis for its high expression, and determine the suitability of any of the genetic elements for use in expression vectors.
The pattern of accumulation of this 50-kDa protein, which for the reasons described in the introduction is called DppA, is shown in Fig. 1 81) , suggesting that it lies counterclockwise to xyl. This was confirmed by a three-factor cross between S1228 (xyl zhj428::TnlO, low DppA level), in which the TnJO is between xyl and mtl, and JM101. P1 grown on S1228 was used to transduce JM101 to Tetr, and the resulting recombinants were scored for xyl and DppA expression. The frequency of Tetr xyl recombinants was higher than of the Tetr, lowDppA-expressing class.
The mapping described above suggested that the gene encoding DppA (dppA) might be near min 80. The following experiment was carried out to test this hypothesis and physically locate dppA. First, the amino-terminal sequence of purified DppA was determined, and degenerate oligonucleotides based on that sequence were prepared ( Fig. 2A) . All four oligonucleotides were used as hybridization probes against DNA from X clones that contained DNA fragments from the min 78 to 80 region of the W3110 chromosome (Fig.  2B) (18) . Figure 2C shows that two of these phages, X9F6 and AlD1, hybridized strongly to the probes, suggesting that dppA (at least the 5' end) was contained in these clones. Restriction enzyme maps of X9F6 and XlD1 were constructed, and the region of hybridization was narrowed to a 0.5-kbp BamHI-EcoRI fragment. This fragment was cloned into the vectors M13mpl8 and M13mpl9, and the DNA sequence was determined. An open reading frame (ORF) was identified 231 bp from the BamHI site that matched the amino acid sequence of DppA in all but the first position; DppA began with Asp-Thr, and the ORF contained codons for Lys-Thr. To obtain the analogous sequence from E1222, a Sau3A partial library of chromosomal DNA was made in the vector XEMBL4, and clones were identified that hybridized to the 1.5-kbp BamHI fragment from X9F6 that contained the putative dppA 5' end. DNA fragments from one of these clones, X10, were used to generate subclones in the vector pBS to use as sequencing templates and for generating RNA probes.
DNA sequence of dppA. The DNA sequence of 1,950 bp from the X10-derived subclones revealed an ORF (nucleotides 231 to 1751) that corresponded to the size and aminoterminal sequence of DppA (Fig. 3) . The ORF, beginning with Lys-231, appears to encode a processed form of the protein, since there is an adjoining upstream sequence that resembles a typical bacterial signal sequence (38, 39) . Assignment of the beginning of this putative signal sequence is complicated by the fact that there are three in-frame Met codons that could potentially serve to signal translation J. BACTERIOL. initiation (Met-204, Met-174, and Met-146). From theoretical considerations, a signal sequence beginning with Met-204 would be too short to function effectively. Translation initiating at Met-146 would result in a leader peptide of 28 amino acids, having three positive charged residues within the first 7 and a core rich in hydrophobic residues, and would end with a sequence fitting the -3, -1 rule for signal peptide cleavage sites.
Expression of dppA from a plasmid. To prove that the ORF identified above encoded DppA, an expression plasmid (pfppl-2) was constructed containing a DNA fragment extending from nucleotide 146 to a PstI site approximately 1 kb downstream from the end of the ORF (see Materials and Methods). The fragment was placed downstream from the lac promoter on a pBR322-based replicon (pSRlac) and introduced into JM101. A protein was observed in these cells that, for the following reasons, we believe to be DppA: (i) it was the same size as purified DppA (Fig. 4A and B, lane 1) , (ii) synthesis was induced upon addition of IPTG (isopropylthiogalactopyranoside) (Fig. 4A and B, lanes 4 and 5), (iii) it was localized to the periplasm (Fig. 4A and B, lanes 6 through 9), and (iv) it reacted with polyclonal antibody made against purified DppA (Fig. 4B) .
DppA is similar to the peptide transport protein OppA. Comparison of dppA with DNA sequences in Gen-Bank and of the deduced DppA amino acid sequence with proteins in the NBRF protein data base revealed that DppA has weak similarity to the oligopeptide-binding protein OppA from S. typhimurium (Fig. 5) (13) . In fact, with these parameters (Fig. 5 legend) transport, an in vivo assay was used based on the observaof dppA in tripeptide transport was not thoroughly investition that amino acid auxotrophies could be phenotypically gated (primarily due to the presence of the other peptide corrected by transporting into the cytoplasm a peptide transport systems); however, cells carrying the containing the required amino acid. Derivatives of JM101 dppA20::Kan allele were checked for their ability to utilize and W3110 that were pro and either dppA+ or dppA::Kan the tripeptide Pro-Gly-Gly as a proline source. In this were tested for growth in M9-glucose containing either experiment, E1769 and E1772 grew to an OD550 of 0.48 and proline or various proline-containing peptides. The results 0.50, respectively, in M9-glucose supplemented with the from one of these experiments (with the W3110 derivatives tripeptide at a final concentration of 100 ,uM, indicating that E1769 and E1772) are shown in Fig. 6 (a similar result was this system is distinct from one or more of the systems obtained with JM101 derivatives; data not shown). The role involved in the uptake of this tripeptide. This result also suggests that the mutation does not confer on the cell an inability to use peptides in general or proline-containing peptides specifically.
Since the dppA20: :Kan mutation is an insertion, it is possible that dppA was not required for dipeptide utilization, but rather the Kanr insertion was polar on the expression of a downstream gene encoding a function that is both necessary and sufficient for Pro-Gly utilization. To test this, two plasmids, the dppA expression plasmid pfppl-2 (see above) and pACDF (a pACYC184 derivative containing a 9-kbp DNA fragment extending from the EcoRI site in dppA to an EcoRI site downstream, see Materials and Methods), were introduced into the pro dppA20::Kan and dppA30::Kan derivatives, and growth on Pro-Gly was determined. Only when both plasmids were present were the insertion mutants complemented for growth on Pro-Gly (data not shown). This result shows that dppA is necessary but not sufficient for dipeptide utilization. Although it is not known exactly what sequence downstream from dppA is required in addition to dppA to complement the Kanr insertion mutation, this result was not unexpected. The organization of genes encoding periplasmic transport systems generally consists of the periplasmic binding protein gene first, followed by genes encod- ing inner membrane components that are also required for transport.
dppA-dependent dipeptide utilization is not dependent on the major proline transport systems. dppA-dependent utilization of Pro-Gly could take place by one of the following mechanisms: (i) active transport of the dipeptide across the inner membrane, followed by cleavage in the cytoplasm, or (ii) DppA cleavage of Pro-Gly in the periplasm, followed by transport of free proline into the cytoplasm. The second possibility was ruled out by showing that a proline auxotroph defective for the three major proline transport systems (strain WG208) could still utilize Pro-Gly. The OD550 of WG208 grown in M9-glucose with either 50 ,uM proline or 50 ,M Pro-Gly was 0.03 and 0.90, respectively. That this growth was dppA dependent was demonstrated by introducing the dppA20::Kan allele into WG208 and showing that the resulting strain, E1974, could no longer use Pro-Gly (OD550 in M9 with 50 ,M proline was 0.03). These results show that dppA-dependent Pro-Gly utilization does not require the normal proline transport systems, and therefore, DppA is part of a transport system for dipeptides rather than merely a Pro-Gly dipeptidase.
The ability of the DppA system to recognize a dipeptide other than Pro-Gly was tested in a competition assay. This assay was based on the assumption that if another peptide could be recognized by DppA, that peptide would lower the growth of a proline auxotroph in limiting concentrations of Pro-Gly. E1769 was grown overnight in M9 supplemented with either proline, Pro-Gly, or a combination of proline plus His-Glu or Pro-Gly plus His-Glu. Proline and the dipeptides were all used at 100 puM. The resulting growth was measured by the OD550. The OD550 of overnight cultures was as follows: no proline source, 0.06; proline, 1.6; Pro-Gly, 0.42; proline plus His-Glu, 1.6; Pro-Gly plus His-Glu, 0.07. Thus, the presence of His-Glu blocked the ability of the cells to use Pro-Gly, indicating that the pathway involving DppA also recognizes other dipeptides. dppA expression is regulated at the level of mRNA. Identifying the mechanism responsible for the differential expression of dppA (as shown in Fig. 1 Fig. 7 . Comparison of the levels of dppA-specific RNA revealed that both the strain-and medium-dependent differences in DppA protein levels were reflected by concomitant changes in mRNA levels.
DISCUSSION
Reported here is the identification and characterization of a gene, dppA, that encodes a periplasmic protein that appears to be a structural component of a dipeptide permease. The major results described in this work include (i) genetic and physical mapping of dppA, (ii) DNA sequence of dppA, (iii) examination of dppA involvement in dipeptide transport, (iv) identification of conserved amino acid residues between DppA and the periplasmic oligonucleotidebinding protein OppA, (v) DppA cellular location, and (vi) transcriptional regulation of dppA expression.
The data presented argue that DppA is part of a general dipeptide transport system. Most compelling is the observation that disruption of the chromosomal copy of dppA by a Kanr insertion eliminates the ability of Pro-Gly to phenotypically correct proline auxotrophy (Fig. 6 ). The following alternative explanations for this result were addressed experimentally. (i) dppA is involved in some other aspect of proline utilization. This was ruled out by showing that growth in minimal medium containing proline was identical with isogenic dppA+ and dppA20::Kan strains (Fig. 6) Another feature common to osmotic-shockable transport systems is the genetic organization of the structural genes (2) . Typically, the first gene in the operon encodes the periplasmic binding protein, followed by genes encoding at least two inner membrane components. If dppA encodes a periplasmic binding protein, it would not be surprising to discover genes downstream that are also required for dipeptide transport. The finding that pACDF (containing a 9-kbp fragment beginning in dppA and extending downstream with respect to dppA) was required, in addition to pfppl-2, to complement the dppA20::Kan mutation suggests that such genes reside in the same operon as dppA. However, the most abundant dppA-hybridizing RNA species (Fig. 7) appears to be too small to encode a multigene operon characteristic of this type of transport system. Either this gene is not part of an operon, or else the higher-molecular-weight RNAs present in the induced culture (although less abundant) represent more of the operon. We think the latter possibility is more likely. If this is correct, then the most abundant band would result from some sort of RNA processing or transcription termination event. Since the promoter for dppA has not been identified and the 3' and 5' ends of the RNA species shown in Fig. 7 have not been localized, the events that lead to these RNA species are unknown.
The ability to genetically map dppA was based on the difference in expression levels between JM101 and most other K-12 strains (including the BW series of Hfr strains). When the min 79 region of the chromosome was crossed from these strains into the JM101 derivative E1222, expression of dppA decreased. Conversely, when this region was crossed from JM101 into other strains (specifically W3110 and S1228), dppA expression increased to resemble that of JM101. Although we do not know what accounts for the difference in expression, steady-state levels of dppA mRNA (Fig. 7) suggest that the two strains differ in a transcriptional element (i.e., promoter, enhancer, repressor, or activator) involved in dppA expression.
Transcription of dppA is repressed by the presence of CAA (Fig. 7) . Thus, the cell alters its ability to transport dipeptides as its nutritional environment changes. This is similar to what is observed with amino acid transport systems. Although each pathway is slightly different, in general, high nitrogen availability represses the expression of genes encoding these systems. In the case of cells grown in minimal medium, it appears that the cell senses a need for amino acids and responds, in part, by inducing transcription of dppA (and thus dipeptide transport capabilities). The components of this signaling system and the mechanism for controlling dppA transcription have not been identified.
As described in the introduction, a 49-kDa periplasmic protein in E. coli has been implicated as being involved in the ability of the cell to utilize and chemotaxis toward dipeptides (24) . This protein, called Dpp, appears to be the same as the protein reported here (23a). Manson et al. (24) also reported that S. typhimurium made Dpp. Consistent with this is our observation that extracts from S. typhimurium LT2 have a protein of about 50 kDa that reacts with antibody to DppA (unpublished data).
